Literature DB >> 21681925

Incidence of childhood leukemia in Yogyakarta, Indonesia, 1998-2009.

Eddy Supriyadi1, Pudjo H Widjajanto, Ignatius Purwanto, Jacqueline Cloos, Anjo J P Veerman, Sutaryo Sutaryo.   

Abstract

BACKGROUND: In most developing countries, incidence data for childhood cancers are less reliable, because very few population-based registries exist. The aim of this study was to present the epidemiology of childhood leukemia in the Dr. Sardjito Hospital (DSH) region, which catchment area extends beyond the boundaries of the Yogyakarta Special Province (YSP). PROCEDURE: Health records of children, 0-14 years of age, who were diagnosed with leukemia between January 1998 and December 2009, were reviewed. Diagnosis of leukemia was confirmed by morphological and histochemical examination of marrow samples.
RESULTS: The estimated average annual incidence rate (AAIR) of childhood acute leukemia in DSH was 46.2 per million per year. Interestingly, the annual incidence rate (AIR) of childhood acute leukemia from the catchment area of DSH significantly increased from 35 in 1999 to 70 in 2009 (ANOVA, P = 0.003). The YSP population data, analyzed separately, showed an increase in AIR from 15.7 to 32.9 (ANOVA, P = 0.325) and an AAIR of 28.8. Remarkably, a relatively high frequency (25.5% in DSH and 27.7% in YSP) of children with AML was found in the group of acute leukemias.
CONCLUSION: The DSH incidence calculations may be overestimated due to an underestimation of the population number. Since the population count for YSP is more precise, the data of YSP were used for comparison with developed countries. AAIR of ALL (20.8) is relatively low compared to Western countries (22.4-37.9). The AAIR of AML (8.0) is similar to Western countries (5.0-8.0) resulting a relatively high percentage of AML versus ALL (27.7%) in YSP.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21681925     DOI: 10.1002/pbc.23109

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

Review 1.  Management of adult and paediatric acute lymphoblastic leukaemia in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013.

Authors:  Allen E J Yeoh; Daryl Tan; Chi-Kong Li; Hiroki Hori; Eric Tse; Ching-Hon Pui
Journal:  Lancet Oncol       Date:  2013-11       Impact factor: 41.316

2.  Clinical characteristics of acute lymphoblastic leukemia in male and female patients: A retrospective analysis of 705 patients.

Authors:  Su-Yi Li; Jie-Yu Ye; Fan-Yi Meng; Chun-Fu Li; M O Yang
Journal:  Oncol Lett       Date:  2015-05-12       Impact factor: 2.967

3.  Differences in childhood leukemia incidence and survival between Southern Thailand and the United States: a population-based analysis.

Authors:  Kathryn Demanelis; Hutcha Sriplung; Rafael Meza; Surapon Wiangnon; Laura S Rozek; Michael E Scheurer; Philip J Lupo
Journal:  Pediatr Blood Cancer       Date:  2015-05-11       Impact factor: 3.167

4.  Spatial clustering of childhood leukaemia with the integration of the Paediatric Environmental History.

Authors:  Alberto Cárceles-Álvarez; Juan A Ortega-García; Fernando A López-Hernández; Mayra Orozco-Llamas; Blanca Espinosa-López; Esther Tobarra-Sánchez; Lizbeth Alvarez
Journal:  Environ Res       Date:  2017-04-26       Impact factor: 6.498

5.  The incidence and mortality of childhood acute lymphoblastic leukemia in Indonesia: A systematic review and meta-analysis.

Authors:  Dina Garniasih; Susi Susanah; Yunia Sribudiani; Dany Hilmanto
Journal:  PLoS One       Date:  2022-06-13       Impact factor: 3.752

6.  Effect of music therapy on cortisol as a stress biomarker in children undergoing IV-line insertion.

Authors:  Idyatul Hasanah; Sri Mulatsih; Fitri Haryanti; Zikrul Haikal
Journal:  J Taibah Univ Med Sci       Date:  2020-04-14

7.  Implementation of Medication Safety Practice in Childhood Acute Lymphoblastic Leukemia Treatment

Authors:  Sri Mulatsih; Iwan Dwiprahasto
Journal:  Asian Pac J Cancer Prev       Date:  2018-05-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.